Close
Show
Home News Page 142

News

This section brings in the latest news and the headlines in the Pharmaceutical industry. Our dedicated news team closely observes the Pharma Industry and keeps you updated of latest developments across the world.

FDA approves Perjeta for people with HER2-positive metastatic breast cancer


Roche announced that the U.S. Food and Drug Administration has approved PerjetaTM.Perjeta is approved...

The challenges and opportunities of clinical trials in developing countries


Conducting more clinical trials in developing countries is of benefit because these populations are...

Novartis drug Gilenya® shows long-term efficacy and safety


New long-term data for Gilenya® (fingolimod), the only oral therapy approved to treat people...

Bristol-Myers Squibb Foundation announces $6 million in grants


The Bristol-Myers Squibb Foundation has announced $6 million in additional grants through its Together...

Alzheimer’s vaccine trial a success


A study led by Karolinska Institutet reports for the first time the positive effects...

Abbott presents phase 3 study results for investigational use of HUMIRA


Abbott announced results from the Phase 3 ABILITY-2 investigational study of HUMIRA  in patients with...

New immune therapy shows promise in kidney cancer


An antibody that helps a person's own immune system battle cancer cells shows increasing promise...

Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma


Results from a study published online in Blood, the Journal of the American Society...

Trastuzumab emtansine reduced the risk of cancer worsening or death


Roche announced that the Phase III EMILIA study of trastuzumab emtansine met its co-primary...

Boehringer Ingelheim expands development capacities with new technical centre


The research driven pharmaceutical company Boehringer Ingelheim is establishing a new 50 million-plus euro...